IP Verse

Medical Device For Dispensing Medicaments - EP2216055

The patent EP2216055 was granted to Bayer on Jun 18, 2025. The application was originally filed on Aug 26, 2003 under application number EP10163581A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2216055

BAYER
Application Number
EP10163581A
Filing Date
Aug 26, 2003
Status
Patent Maintained As Amended
May 16, 2025
Grant Date
Jun 18, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BECTONApr 26, 2018HOFFMANN EITLE -
BIOTRONIKApr 26, 2018ARTH -
COOK MEDICALApr 26, 2018WILLIAMS POWELL -
HEMOTEQApr 25, 2018ARTH -
BOSTON SCIENTIFICApr 24, 2018PETERREINS SCHLEY -

Patent Citations (61) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS5102402
DESCRIPTIONWO0124866
EXAMINATIONDE10115740
EXAMINATIONWO02076509
OPPOSITIONEP0519063
OPPOSITIONEP1140273
OPPOSITIONEP1539266
OPPOSITIONEP1666070
OPPOSITIONUS2001037140
OPPOSITIONUS2002098278
OPPOSITIONUS5102402
OPPOSITIONUS5147302
OPPOSITIONUS5209799
OPPOSITIONUS5318587
OPPOSITIONUS5342307
OPPOSITIONUS5350361
OPPOSITIONUS5370614
OPPOSITIONUS5456666
OPPOSITIONUS5496276
OPPOSITIONUS5681522
OPPOSITIONUS5716981
OPPOSITIONUS5738901
OPPOSITIONUS5916596
OPPOSITIONUS5977163
OPPOSITIONUS5980972
OPPOSITIONUS6013055
OPPOSITIONUS6013092
OPPOSITIONUS6033380
OPPOSITIONUS6039721
OPPOSITIONUS6071285
OPPOSITIONUS6146358
OPPOSITIONUS6364856
OPPOSITIONWO0021584
OPPOSITIONWO0032238
OPPOSITIONWO0032267
OPPOSITIONWO0044414
OPPOSITIONWO0045744
OPPOSITIONWO0124866
OPPOSITIONWO0149268
OPPOSITIONWO02076509
OPPOSITIONWO2004006976
OPPOSITIONWO2004028582
OPPOSITIONWO9211890
OPPOSITIONWO9423787
OPPOSITIONWO9625176
OPPOSITIONWO9814174
OPPOSITIONWO9830249
OPPOSITIONWO9836784
OPPOSITIONWO9908729
OPPOSITIONWO9925336
OTHERUS5370613
OTHERWO0044414
OTHERWO9908729
SEARCHDE4225553
SEARCHUS2002123505
SEARCHUS5370614
SEARCHWO0044414
SEARCHWO0045744
SEARCHWO2004006976
SEARCHWO9211890
SEARCHWO9215282

Non-Patent Literature (NPL) Citations (11) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Küsters S., "Tauchbeschichtung von ballons mit paclitaxel nach dem verfahren von prof. speck", ABK, (20040825), pages 1 - 5-
OPPOSITION- LAMBERT B.J. ET AL, "POLYMERS IN MEDICAL APPLICATIONS", Rapra Review Report 127, (20010700), vol. 11, no. 7, pages 18 - 19, XP055485324-
OPPOSITION- Mark A. Saab, "Applications of High-Pressure Balloons in the Medical Device Industry", Medical Device & Diagnostic Industry Magazine (MDDI), (20000901), URL: https://www.mddionline.com/applications-high-pressure-balloons-medical-device-industry, XP055485778-
OPPOSITION- Matsumoto; Et Al, "Peripheral angioplasty balloon technology", Cardiovasc Intervent Radiol, (19930000), vol. 16, pages 135 - 143, XP055485041-
OPPOSITION- MATSUMOTO et al., "peripheral angioplasty balloon technology", Cardiovasc Intervent Radiol, (19930000), vol. 16, pages 135 - 143, XP055485041-
OPPOSITION- MOUKWA, "The Development of Polymer-Based Biomaterials Since the 1920s", JOM, (19970000), pages 46 - 50, XP055485050-
OPPOSITION- MOUKWA, "The Development of Polymer-Based Biomaterials Since the 1920s", JOM, (19970201), pages 46 - 50, XP055485050-
OPPOSITION- Nordson Medical, "Applications of High-Pressure Balloons in the Medical Device Industry", Nordson Medical brochure, (20170000), pages 1 - 17, XP055485785-
OPPOSITION- RAMAKRISHNA et al., "Biomedical applications of polymer-composite materials: a review", Composites Science and Technology, (20010000), vol. 61, pages 1189 - 1224, XP055485058-
OPPOSITION- HERDEG C; ET AL, "PACLITAXEL: EIN CHEMOTHERAPEUTIKUM ZUR RESTENOSEPROPHYLAXE? EXPERIMENTELLE UNTERSUCHUNGEN IN VITRO UND IN VIVO//PACLITAXEL: AN ANTI-CANCER AGENT FOR THE PREVENTION OF RESTENOSIS? RESULTS FROM EXPERIMENTAL IN VITRO AND IN VIVO STUDIES", ZEITSCHRIFT FUER KARDIOLOGIE,, (20000501), vol. 89, no. 5, pages 390 - 397, XP001148139
OPPOSITION- HERDEG et al., "PACLITAXEL: EIN CHEMOTHERAPEUTIKUM ZUR RESTENOSEPROPHYLAXE? EXPERIMENTELLE UNTERSUCHUNGEN IN VITRO UND IN VIVO", Z. Kardol., (20000000), vol. 89, pages 390 - 397, XP001148139

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents